These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29768290)

  • 1. Intense aerobic exercise lowers blood pressure in individuals with metabolic syndrome taking antihypertensive medicine.
    Ramirez-Jimenez M; Fernandez-Elias V; Morales-Palomo F; Ortega JF; Mora-Rodriguez R
    Blood Press Monit; 2018 Oct; 23(5):230-236. PubMed ID: 29768290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intense aerobic exercise and/or antihypertensive medication in individuals with metabolic syndrome.
    Ramirez-Jimenez M; Morales-Palomo F; Ortega JF; Mora-Rodriguez R
    Scand J Med Sci Sports; 2018 Sep; 28(9):2042-2051. PubMed ID: 29771450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-exercise Hypotension Produced by Supramaximal Interval Exercise is Potentiated by Angiotensin Receptor Blockers.
    Ramirez-Jimenez M; Morales-Palomo F; Ortega JF; Mora-Rodriguez R
    Int J Sports Med; 2019 Nov; 40(12):756-761. PubMed ID: 31476782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antihypertensive medication and high-intensity interval training in hypertensive metabolic syndrome individuals.
    Ramirez-Jimenez M; Morales-Palomo F; Moreno-Cabañas A; Alvarez-Jimenez L; Ortega JF; Mora-Rodriguez R
    Scand J Med Sci Sports; 2021 Jul; 31(7):1411-1419. PubMed ID: 33662166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness.
    Andreadis EA; Sfakianakis ME; Tsourous GI; Georgiopoulos DX; Fragouli EG; Katsanou PM; Tavoularis EI; Skarlatou MG; Marakomichelakis GE; Ifanti GK; Diamantopoulos EJ
    Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of direct renin inhibitor and angiotensin II receptor blocker on clinic and ambulatory blood pressure profiles in hypertension with chronic kidney disease.
    Uneda K; Tamura K; Wakui H; Azushima K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Ohsawa M; Fujikawa T; Umemura S
    Clin Exp Hypertens; 2016; 38(8):738-743. PubMed ID: 27936941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
    Musini VM; Nazer M; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension.
    Heran BS; Wong MM; Heran IK; Wright JM
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD003822. PubMed ID: 18843650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
    Agarwal R; Weir MR
    J Hypertens; 2013 Aug; 31(8):1692-701. PubMed ID: 23697963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome.
    Nashar K; Nguyen JP; Jesri A; Morrow JD; Egan BM
    Am J Hypertens; 2004 Jun; 17(6):477-82. PubMed ID: 15177518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure response to a bout of HIIT in metabolic syndrome patients.
    Ramirez-Jimenez M; Morales-Palomo F; Pallares JG; Mora-Rodriguez R; Ortega JF
    Eur J Appl Physiol; 2017 Jul; 117(7):1403-1411. PubMed ID: 28493030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan/hydrochlorothiazide combination therapy surpasses high-dose angiotensin receptor blocker in the reduction of morning home blood pressure in patients with morning hypertension.
    Hanayama Y; Uchida HA; Nakamura Y; Makino H
    Acta Med Okayama; 2012; 66(6):449-59. PubMed ID: 23254579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant responses to two classes of drugs acting on the renin-angiotensin system.
    Sever PS; Chang CL
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):25-30. PubMed ID: 11881062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring.
    Fabia MJ; Abdilla N; Oltra R; Fernandez C; Redon J
    J Hypertens; 2007 Jul; 25(7):1327-36. PubMed ID: 17563549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.